Notice of Extension of Application Due Date for RFA-DK-21-019, National Program for the Career Development Of Physician Scientists in Diabetes Research (Diabetes - Docs) (K12 Clinical Trial Optional)
Notice NOT-DK-21-030 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 30, 2021 Category: Research Source Type: funding
Notice of Change to Award Information and Application and Submission Instructions for RFA-DK-21-019, National Program for the Career Development Of Physician Scientists in Diabetes Research (Diabetes - Docs) (K12 Clinical Trial Optional)
Notice NOT-DK-21-027 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 20, 2021 Category: Research Source Type: funding
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-21-332 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for support of investigator-initiated studies addressing mechanisms by which bariatric surgery impacts cancer risk, and seeks to draw in talented scientists who study bariatric surgery to investigate its effects on cancer, rather than shorter term outcomes such as weight loss and diabetes. The goal of this FOA is to support proof of concept studies for feasibility and exploratory development. Feasibility must not have already been devel...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 3, 2021 Category: Research Source Type: funding
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
Funding Opportunity PAR-21-331 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for support of investigator-initiated studies addressing mechanisms by which bariatric surgery impacts cancer risk, and seeks to draw in talented scientists who study bariatric surgery to investigate its effects on cancer, rather than shorter-term outcomes such as weight loss and diabetes. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 3, 2021 Category: Research Source Type: funding
National Program for the Career Development Of Physician Scientists in Diabetes Research (Diabetes - Docs) (K12 Clinical Trial Optional)
Funding Opportunity RFA-DK-21-019 from the NIH Guide for Grants and Contracts. The purpose of the Development Of Physician Scientists in Diabetes research (Diabetes-DOCS) Program is to support the career development of physicians committed to a career in diabetes research. The Diabetes-DOCS program is intended to remedy the dearth of pediatric endocrinologists and physicians from other specialties conducting outstanding, innovative research into the causes and consequences of diabetes. Diabetes-DOCS will be a single national program, implemented by one or more PD/PIs, together with an advisory committee composed of basi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 31, 2021 Category: Research Source Type: funding
Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
Funding Opportunity PAR-21-313 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to provide support for new investigators from diverse backgrounds, including from groups nationally underrepresented in biomedical research, to conduct small research projects in the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and participating Institutes and Centers. New investigators at the time of award under this FOA will have/have had less than $125,000 direct costs of combined research funding (excluding NIH training a...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 20, 2021 Category: Research Source Type: funding
Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-21-503 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to continue to follow the Epidemiology of Diabetes Interventions and Complications (EDIC) cohort through a collaborative cooperative agreement. EDIC is an observational study that was launched at the completion of the Diabetes Control and Complications Trial (DCCT) trial. The DCCT showed that intensive therapy significantly reduced the risk of diabetes complications compared to conventional therapy. At DCCT completion, all cohort members were taught intensive diabetes therapy. In 1...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 17, 2021 Category: Research Source Type: funding
Request for Information: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Strategic Plan Draft Document
Notice NOT-DK-21-025 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 10, 2021 Category: Research Source Type: funding
Cardiovascular Biorepository for Type 1 Diabetes (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-21-010 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites a single cooperative agreement application to establish a biorepository of human cardiovascular (CV) tissue and an infrastructure for discovery and mechanistic research to increase our knowledge of the CV complications of type 1 diabetes (T1D). Cardiovascular disease (CVD) is the leading cause of death and morbidity for individuals with T1D, but no T1D-specific therapy exists to prevent or treat this complication of diabetes because of challenges from inadequate preclinical models, decades-l...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 4, 2021 Category: Research Source Type: funding
Pilot and Feasibility Studies to Improve Technology Adoption and Reduce Health Disparities in Type 1 Diabetes Mellitus (R01 Clinical Trial Required)
Funding Opportunity RFA-DK-21-018 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support pilot and feasibility trials of interventions designed to improve technology adoption in individuals from underrepresented backgrounds with type 1 diabetes mellitus (T1D). Through successful execution, these pilot and feasibility trials should provide feasibility data for larger, pragmatic trials with the overarching goal of reducing health disparity in T1D through improving technology usage in individuals from minority racial and ethnic backgrounds. (Source: NIH Funding...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 28, 2021 Category: Research Source Type: funding
Notice of Special Interest: Administrative Supplements to Support Emerging Physician-Scientists to Develop Research Expertise in Diabetes, Endocrinology and Metabolic Diseases
Notice NOT-DK-21-022 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 19, 2021 Category: Research Source Type: funding
Notice of Early Expiration of NOT-DK-20-040 "Notice of Special Interest: Administrative Supplements to Support Emerging Physician-Scientists to Develop Research Expertise in Diabetes, Endocrinology and Metabolic Diseases"
Notice NOT-DK-21-023 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 19, 2021 Category: Research Source Type: funding
Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Biostatistics Research Center (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-21-003 from the NIH Guide for Grants and Contracts. This FOA invites applications for a Biostatistics Research Center to participate in a clinical consortium to better understand youth-onset type 2 diabetes. A separate FOA (RFA-DK-21-002) invites Clinical Centers to recruit a cohort of early pubertal youth at risk for developing type 2 diabetes and study them through puberty. The ultimate goals of this consortium will be to 1) develop more precise prediction of which individuals are truly at risk for developing youth-onset T2D and identify determinants of progression from prediabetes to T2D so...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 14, 2021 Category: Research Source Type: funding
Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-21-002 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to ?c?r?e?a?t?e? ?a? ?c?l?i?n?i?c?a?l? consortium to recruit a cohort o?f early pubertal youth at risk for developing type 2 diabetes and study them th?r?o?ugh puberty. The ultimate goal of this undertaking will be to 1) develop more precise prediction of which individuals are truly at risk for developing you?t?h-onset T2D and identify determinants of progression from prediabetes to T2D so that, ultimately, targeted prevention approaches can be developed and tested; and 2) increase understanding ofthe physiologic dr...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 14, 2021 Category: Research Source Type: funding
Continuation of The Collaborative Islet Transplantation Registry (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-21-013 from the NIH Guide for Grants and Contracts. This FOA invites applications for continuation of the Collaborative Islet Transplantation Registry? (CITR). Since 2001, this Registry has compiled and analyzed islet transplantation data with the intent to capture all clinical activity in North America as well as additional sites in other countries. Currently, data on both allo- and autotransplantation are collected. The registry will collect data and develop and maintain sophisticated databases to be used by the research community for publications? and presentations. CITR will also prepare a...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 14, 2021 Category: Research Source Type: funding
